Trial intelligence / Profile preview

Monoclonal Factor IX Concentrate for Factor IX Deficiency

NCT00004801Phase 2Completed

Sponsor
National Center for Research Resources
Start
Mar 1992
Modality
Replacement Enzymes
01

Overview

A Phase 2 trial of coagulation factor ix in hemophilia B (HB), sponsored by National Center for Research Resources. Started Mar 1992; status: completed.

02

Drugs

coagulation factor ix
03

Conditions

hemophilia B (HB)

Beyond the preview

Go deeper on NCT00004801.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004801.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call